BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Yordanov E, Parvova I, Hristov E, Petkova V. Evaluation of the drug utilization of biosimilar medicinal products containing monoclonal antibodies: A systematic review. Journal of Generic Medicines 2022;18:145-153. [DOI: 10.1177/17411343221076371] [Reference Citation Analysis]
2 Nachev N, Stoyanova S, Rangelov A, Yordanov E, Hristov EI, Parvova I, Petkova V. Retrospective analysis of drug utilization and rational drug use in treatment of essential arterial hypertension in Bulgaria: Generic perception. Journal of Generic Medicines 2022;18:88-98. [DOI: 10.1177/17411343211055896] [Reference Citation Analysis]
3 Kamusheva M, Georgieva V, Marinov L, Boncheva E, Milushewa P, Grigorova P, Marinov K, Petrova G. Volume and trends of adalimumab and pembrolizumab reimbursed market: the Bulgarian perspective. Biotechnology & Biotechnological Equipment 2021;35:1778-91. [DOI: 10.1080/13102818.2021.2019116] [Reference Citation Analysis]